Medical Condition News

RSS

FDA grants marketing approval for VALCHLOR gel for treatment of early stage CTCL

Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.

26 Aug 2013

Immune Pharmaceuticals announces completion of merger with EpiCept Corporation

Immune Pharmaceuticals Inc. announced today the completion of the merger of Immune Pharmaceuticals Ltd. and EpiCept Corporation.

26 Aug 2013

Scientists receive NIH grant to study commercially-available drug for treatment of PMS

Scientists at the Seaver Autism Center at the Icahn School of Medicine at Mount Sinai have received a grant from the National Institutes of Health (NIH) to study Insulin-Like Growth Factor-1 (IGF-1), a promising treatment for a subtype of autism called Phelan McDermid Syndrome (PMS).

26 Aug 2013

The way gut "tastes" sweet food may be defective in sufferers of type 2 diabetes

Researchers at the University of Adelaide have discovered that the way the gut "tastes" sweet food may be defective in sufferers of type 2 diabetes, leading to problems with glucose uptake.

26 Aug 2013

Screening strategy for ovarian cancer appears to be highly specific for detecting disease at early stages

A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal. The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. If verified in an ongoing clinical trial, it could potentially help save the lives of thousands of women each year in the United States alone.

26 Aug 2013

Scientists identify specific type of receptor that may aid in treatment of AD, Parkinson’s disease

Scientists at Washington University School of Medicine in St. Louis have found a way that corrupted, disease-causing proteins spread in the brain, potentially contributing to Alzheimer's disease, Parkinson's disease and other brain-damaging disorders.

26 Aug 2013

Researchers review limited literature available on PTSD prevention

Current research indicates that at some point in their life up to 84% of people will be exposed to some form of traumatic event. Although effective post-traumatic stress disorder treatments have been - and continue to be - developed, there remains a lack in relevant research pertaining to the prevention of PTSD.

26 Aug 2013

Post-doctoral fellow receives grant from NIH to study the response levels to FES in stroke patients

Rakesh Pilkar, Ph.D., a post-doctoral fellow in Human Performance and Engineering Research at Kessler Foundation, was awarded a R03, $153,000 grant by the National Institutes of Health to study the response levels to function electrical stimulation (FES) interventions in the rehabilitation of stroke patients-titled, "Identification of Responders to the FES Interventions in Stroke Populations".

26 Aug 2013

Study reports racial, ethnic differences in incidence of soft tissue sarcomas in young adults, adolescents

Mei-Chin Hsieh, MSPH, CTR, of LSU Health Sciences Center New Orleans School of Public Health's Louisiana Tumor Registry, is the lead author of a study that reports racial and ethnic differences in the incidence of soft tissue sarcomas in adolescents and young adults.

26 Aug 2013

Researchers discover additional cystic fibrosis-causing mutations

Of the over 1,900 errors already reported in the gene responsible for cystic fibrosis, it is unclear how many of them actually contribute to the inherited disease. Now a team of researchers reports significant headway in figuring out which mutations are benign and which are deleterious. In so doing, they have increased the number of known CF-causing mutations from 22 to 127, accounting for 95 percent of the variations found in patients with CF.

26 Aug 2013

BESTCILIA project aims to improve screening, treatment of Primary Ciliary Dyskinesia

Primary Ciliary Dyskinesia is mainly a lung disease: a rare, genetically heterogeneous disorder resulting from dysfunction of small hair-like organelles (cilia) that clean the upper and lower airways. It can also affect multiple organs beside the respiratory system, and may cause serious impairment and lower quality of life. Its prevalence is estimated to be about 1 in 16,000.

26 Aug 2013

Study identifies 22 locations in the human genome that cause schizophrenia

A new genome-wide association study estimates the number of different places in the human genome that are involved in schizophrenia.

26 Aug 2013

Houston scientists receive $1.3M grant to study how immune system drives multiple sclerosis

A $1.3 million grant from the National Institute of Neurological Disorders and Stroke could help Houston Methodist scientists better understand how the body's own immune system drives multiple sclerosis.

26 Aug 2013

Scanning technique reveals how brain tumor responds to drug administered

A new scanning technique developed by Danish and US researchers reveals how susceptible patients with aggressive brain cancer are to the drugs they receive. The research behind the ground-breaking technique has just been published in Nature Medicine.

26 Aug 2013

Higher intake of fruits and vegetables may reduce risk of bladder cancer in women: Study

University of Hawaii Cancer Center Researcher Song-Yi Park, PhD, along with her colleagues, recently discovered that a greater consumption of fruits and vegetables may lower the risk of invasive bladder cancer in women.

26 Aug 2013

Smartphone-based portable device to conduct kidney tests invented at UCLA

A lightweight and field-portable device invented at UCLA that conducts kidney tests and transmits data through a smartphone attachment may significantly reduce the need for frequent office visits by people with diabetes and others with chronic kidney ailments.

26 Aug 2013

Researchers discover link between epilepsy drug and risk of having baby with birth defects

In a world first, new Australian medical research has given pregnant women with epilepsy new hope of reducing their chance of having a baby with physical birth defects.

26 Aug 2013

Model including dozens of mutations helps clarify genetic factors involved in Crohn's disease

A statistical model accounting for dozens of different genes in combination-and the interactions between them-is an important step forward in understanding the genetic factors affecting the risk of Crohn's disease (CD), reports a study in Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America (CCFA). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

26 Aug 2013

Glutathione peroxidase activity protects against symptoms of Huntington's disease

Leicester geneticists have discovered a potential defence against Huntington's disease - a fatal neurodegenerative disorder which currently has no cure.

26 Aug 2013

DeNovoGear software uses statistical probabilities to help identify genetic mutations

Concealed within the vastness of the human genome, (comprised of some 3 billion base pairs), mutations are commonplace. While the majority of these appear to have neutral effect on human health, many others are associated with diseases and disease susceptibility.

26 Aug 2013

Medical Condition News

FDA grants marketing approval for VALCHLOR gel for treatment of early stage CTCL

Immune Pharmaceuticals announces completion of merger with EpiCept Corporation

Scientists receive NIH grant to study commercially-available drug for treatment of PMS

The way gut "tastes" sweet food may be defective in sufferers of type 2 diabetes

Screening strategy for ovarian cancer appears to be highly specific for detecting disease at early stages

Scientists identify specific type of receptor that may aid in treatment of AD, Parkinson’s disease

Researchers review limited literature available on PTSD prevention

Post-doctoral fellow receives grant from NIH to study the response levels to FES in stroke patients

Study reports racial, ethnic differences in incidence of soft tissue sarcomas in young adults, adolescents

Researchers discover additional cystic fibrosis-causing mutations

BESTCILIA project aims to improve screening, treatment of Primary Ciliary Dyskinesia

Study identifies 22 locations in the human genome that cause schizophrenia

Houston scientists receive $1.3M grant to study how immune system drives multiple sclerosis

Scanning technique reveals how brain tumor responds to drug administered

Higher intake of fruits and vegetables may reduce risk of bladder cancer in women: Study

Smartphone-based portable device to conduct kidney tests invented at UCLA

Researchers discover link between epilepsy drug and risk of having baby with birth defects

Model including dozens of mutations helps clarify genetic factors involved in Crohn's disease

Glutathione peroxidase activity protects against symptoms of Huntington's disease

DeNovoGear software uses statistical probabilities to help identify genetic mutations

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News